Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

THE TRUTH ABOUT: Villagemd | History Defined

Public health and private equity: What the Walgreens buyout could mean for the future of pharmacy care

Pharmacies are more than just stores – they’re vital links between people and their health care.

The Conversation

Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet

Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer.

MarketBeat

Is Walgreens Stock a Buy Thanks to Its Fat 9% Dividend Yield?

Walgreens (WBA) is attempting to turn around its struggling business with a new strategic vision and leadership, offering an enticing 10.7% dividend yield

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

What to Expect Walgreens Boots Alliance's Next Quarterly Earnings Report

With Walgreens Boots Alliance expected to release its Q4 earnings in October, analysts project a double-digit profit dip.

Barchart

Walgreens to take a hard look at underperforming stores, could shutter hundreds more

Walgreens is finalizing a plan to fix its business that could result in the closure of hundreds of additional stores in the next three years

The Independent UK

Walmart says it will close its 51 health centers and virtual care service

The Arkansas-based company said that after managing the clinics it launched in 2019 and expanding its telehealth program, it concluded "there is not a sustainable business model for us to continue."

WEKU

Is This Dividend Aristocrat a Buy for Its 9% Yield?

Walgreens Boots Alliance currently offers shareholders the highest dividend yield on the Dow. But how long can WBA keep hiking its dividend amid narrowing profit margins?

Barchart

Read news from The Economist, FT, and more,
with one subscription

Walgreens aims to cut more costs amid weaker demand for COVID vaccines, uncertain economy

Walgreens Boots Alliance is raising its cost-savings goal by 17% to $4.1 billion after a disappointing quarter — a move that comes just weeks after it said it was eliminating 10% of its corporate workforce.

Chicago Tribune

CVS buying Chicago’s Oak Street Health in deal valued at $10.6 billion

CHICAGO — CVS Health plans to buy Chicago-based Oak Street Health in a $10.6 billion deal that aims to expand CVS’s reach into primary care.

Chicago Tribune

CVS buys Chicago-based Oak Street Health for $10.6B

Oak Street Health runs primary care centers mostly for lower-to-middle income people with Medicare Advantage plans.

Chicago Sun-Times

Walgreens’ VillageMD buys another urgent and primary care chain for $9 billion

Walgreens and rival CVS have evolved in recent years far beyond their historic focus on store sales and filling prescriptions.

Chicago Sun-Times

Chicago-based VillageMD to pay $8.9 billion to acquire care provider, with help from Walgreens

Chicago-based VillageMD, which has primary care clinics in Walgreens stores across the country, will pay $8.9 billion to acquire a company that will help it to branch into specialty and urgent care and grow its footprint dramatically.

Chicago Tribune

Tesla Explored Minority Stake In Glencore, TuSimple Fires Its CEO Amid Regulatory Scrutiny, Twitter Could Reportedly Lose A Fourth Of Its Employees After Takeover: Top Stories Monday, Oct. 31

Washington Post

Benzinga

RBC Says This Pharmacy Chain Has Health Investments On Track Despite Abandoning Divestiture

RBC Capital Markets lowered the price target on Walgreens Boots Alliance Inc (NASDAQ:WBA) to $42 (10% upside) from $46 and maintained the Sector Perform rating. The analysts say that WBA posted solid fiscal 3Q22 results slightly ahead of their estimates and consensus on steady execution in the U.S. against a difficult comp and continued…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Walgreens Launches Clinical Trial Business

Walgreens Boots Alliance Inc (NASDAQ:WBA) has launched its clinical trial business to redefine the patient experience and increase access and retention in sponsor-led drug development research. Walgreens will combine the flexible clinical trial model with its vast data on patient insights, partner-enabled health and technology capabilities, and in-person and virtual care options. The…

The Philadelphia Inquirer

Q&A: Penn ethicist Zeke Emanuel has another life as a venture capitalist

Ezekiel Emanuel chairs the department of medical ethics and health policy at the University of Pennsylvania. He started the bioethics department at the National Institutes of Health, helped shape U.S. health-care policy as a senior aide in the Obama administration, served on President Joe Biden's COVID-19 task force, and advocates…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.